These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2999002)

  • 1. Epidemic of LAV/HTLV III infection in drug addicts in Milan: serological survey and clinical follow-up.
    Lazzarin A; Galli M; Geroldi D; Zanetti A; Crocchiolo P; Aiuti F; Moroni M
    Infection; 1985; 13(5):216-8. PubMed ID: 2999002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to AIDS-associated retrovirus (HTLV-III/LAV) in drug addicts from Vizcaya, northern Spain.
    Merino F; Esparza B; Aizpiri J; Fernandez J; de Masdelval L; Arrieta A; Velazquez M; Volsky DJ; San Cristobal E; de Izaguirre A
    AIDS Res; 1986; 2(2):133-40. PubMed ID: 3013221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy.
    De Rossi A; Gassa OD; del Mistro A; Faulkner Valle G; Bianchi LC
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):411-8. PubMed ID: 3015630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
    Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
    Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.
    Hunsmann G; Schneider J; Bayer H; Kurth R; Werner A; Brede HD; Erfle V; Mellert W; Brodt HR; Bergmann L
    Klin Wochenschr; 1985 Mar; 63(5):233-5. PubMed ID: 2985862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
    J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory results in the evaluation of anti HTLV-III in subjects at risk].
    Maschio C; Colangeli S; Rughetti A; Fonzi D; Barnabei R; Ciccarella A
    Riv Emoter Immunoematol; 1985; 32(3):302-6. PubMed ID: 3008301
    [No Abstract]   [Full Text] [Related]  

  • 17. Outbreak of persistent, unexplained, generalized lymphadenopathy with immunological abnormalities in drug addicts in Milan.
    Lazzarin A; Galli M; Introna M; Negri C; Mantovani A; Mella L; Ferrante P; Parravicini C; Trombini M; Aiuti F
    Infection; 1984; 12(6):372-6. PubMed ID: 6097548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.
    Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC
    JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of HTLV-III infection in intravenous drug users in Liguria, Italy.
    Cuneo Crovari P; Terragna A; Robert L; Orlando G; Rizzo F; Piuma-Fusco M; Icardi GC; Papa D; Di Ponzio A; Auteri G
    Boll Ist Sieroter Milan; 1985; 64(4):339-42. PubMed ID: 3000406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.